Dr. Samuel Funt, MD

Claim this profile

Memorial Sloan Kettering Bergen

Studies Transitional Cell Carcinoma
Studies Bladder Cancer
4 reported clinical trials
9 drugs studied

Area of expertise

1

Transitional Cell Carcinoma

Samuel Funt, MD has run 2 trials for Transitional Cell Carcinoma. Some of their research focus areas include:

Stage IV
Stage III
2

Bladder Cancer

Samuel Funt, MD has run 2 trials for Bladder Cancer. Some of their research focus areas include:

Stage IV
Stage III

Affiliated Hospitals

Image of trial facility.

Memorial Sloan Kettering Bergen

Image of trial facility.

Memorial Sloan Kettering Cancer Center (All Protocol Activities)

Clinical Trials Samuel Funt, MD is currently running

More about Samuel Funt, MD

Clinical Trial Related

8 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 1 Active Clinical Trial

Treatments Samuel Funt, MD has experience with

  • Durvalumab, Tremelimumab
  • Atezolizumab
  • Cisplatin
  • Gemcitabine
  • Durvalumab
  • Radiation Therapy

Other Doctors you might be interested in

Frequently asked questions

Do I need insurance to participate in a trial?

What does Samuel Funt, MD specialize in?

Is Samuel Funt, MD currently recruiting for clinical trials?

Are there any treatments that Samuel Funt, MD has studied deeply?

What is the best way to schedule an appointment with Samuel Funt, MD?

What is the office address of Samuel Funt, MD?

Is there any support for travel costs?